Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
CRE8 sirolimus-eluting stent
DEVICE
2 trials
Sponsors
CID S.p.A.
Conditions
Coronary Artery Disease
Phase 3
Safety and Efficacy of the CRE8 Stent for the Treatment of De Novo Coronary Artery Lesions
NCT02360423
CID S.p.A.
Coronary Artery Disease
Start: 2014-11-30
End: 2021-04-30
Target: 430
Updated: 2015-03-25
Unknown Phase
Safety and Efficacy of the CRE8 Sirolimus-Eluting Stent for the Treatment of De Novo Coronary Artery Lesions
NCT02360709
CID S.p.A.
Coronary Artery Disease
Start: 2014-11-30
End: 2021-04-30
Target: 800
Updated: 2015-03-25